Intracellular Expression of CTB in Vibrio cholerae Strains in Laboratory Culture Conditions
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
The introduction of the toxT-139F allele triggers the expression of TCP (toxin co-regulated pilus) and CT (cholera toxin) under simple laboratory culture conditions in most Vibrio cholerae strains. Such V. cholerae strains, especially strains that have been used in OCVs (oral cholera vaccines), can induce antibody responses against TCP in animal models. However, CT produced in these V. cholerae strains is secreted into the culture medium. In this study, V. cholerae strains that can express intracellular CTB under the control of the toxT-139F allele have been constructed for potential application in OCVs. First, we constructed a recombinant plasmid directly linking the ctxAB promoter to ctxB without ctxA and confirmed CTB expression from the plasmid in V. cholerae containing the toxT-139F allele. We constructed another recombinant plasmid to express NtrCTB, from which 14 internal amino acids—from the 7th to the 20th amino acid—of the leader peptide of CTB have been omitted, and we found that NtrCTB remained in the cells. Based on those results, we constructed V. cholerae strains in which chromosomal ctxAB is replaced by ntrctxB or ntrctxB-dimer. Both NtrCTB and NtrCTB-dimer remained in the bacterial cells, and 60% of the NtrCTB-dimer in the bacterial cells was maintained in a soluble form. To develop improved OCVs, these strains could be tested to see whether they induce immune responses against CTB in animal models.
Abstract
The introduction of the toxT-139F allele triggers the expression of TCP (toxin co-regulated pilus) and CT (cholera toxin) under simple laboratory culture conditions in most Vibrio cholerae strains. Such V. cholerae strains, especially strains that have been used in OCVs (oral cholera vaccines), can induce antibody responses against TCP in animal models. However, CT produced in these V. cholerae strains is secreted into the culture medium. In this study, V. cholerae strains that can express intracellular CTB under the control of the toxT-139F allele have been constructed for potential application in OCVs. First, we constructed a recombinant plasmid directly linking the ctxAB promoter to ctxB without ctxA and confirmed CTB expression from the plasmid in V. cholerae containing the toxT-139F allele. We constructed another recombinant plasmid to express NtrCTB, from which 14 internal amino acids—from the 7th to the 20th amino acid—of the leader peptide of CTB have been omitted, and we found that NtrCTB remained in the cells. Based on those results, we constructed V. cholerae strains in which chromosomal ctxAB is replaced by ntrctxB or ntrctxB-dimer. Both NtrCTB and NtrCTB-dimer remained in the bacterial cells, and 60% of the NtrCTB-dimer in the bacterial cells was maintained in a soluble form. To develop improved OCVs, these strains could be tested to see whether they induce immune responses against CTB in animal models.
참고문헌 (43)
- Kaper JB, "Cholera", Clin. Microbiol. Rev, 8, pp.48~86 (1995)
- Clemens JD, "Cholera", Lancet, 390, pp.1539~1549 (2017)
- Kim EJ, "Whole-genome sequence comparisons reveal the evolution of Vibrio cholerae O1", Trends Microbiol, 23, pp.479~489 (2015)
- Safa A, "Evolution of new variants of Vibrio cholerae O1", Trends Microbiol, 18, pp.46~54 (2010)
- Herrington DA, "Toxin, toxin-coregulated pili, and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans", J. Exp. Med, 168, pp.1487~1492 (1988)
- Miller VL, "Synthesis of cholera toxin is positively regulated at the transcriptional level by toxR", Proc. Natl. Acad. Sci. USA, 81, pp.3471~3475 (1984)
- Childers BM, "Regulation of virulence in Vibrio cholerae: the ToxR regulon", Future Microbiol, 2, pp.335~344 (2007)
- Baek Y, "Cholera toxin production in Vibrio cholerae O1 El Tor biotype strains in single-phase culture", Front. Microbiol, 11, pp.825~ (2020)
- Lee D, "Alterations in glucose metabolism in Vibrio cholerae serogroup O1 El Tor biotype strains", Sci. Rep, 10, pp.308~ (2020)
- Kim Eun Jin, "Inactivated Vibrio cholerae Strains That Express TcpA via the toxT -139F Allele Induce Antibody Responses against TcpA", Journal of Microbiology and Biotechnology, 32(11), pp.1396~1405 (2022), 한국미생물·생명공학회[DOI]
- Kim EJ, "Replication of Vibrio cholerae classical CTX phage", Proc. Natl. Acad. Sci. USA, 114, pp.2343~2348 (2017)
- Ghosh-Banerjee J, "Cholera toxin production by the El Tor variant of Vibrio cholerae O1 compared to prototype El Tor and classical biotypes", J. Clin. Microbiol, 48, pp.4283~4286 (2010)
- Shaikh H, "Current and future cholera vaccines", Vaccine, 38(Suppl 1), pp.A118~A126 (2020)
- Lopez AL, "Killed oral cholera vaccines: history, development and implementation challenges", Ther. Adv. Vaccines, 2, pp.123~136 (2014)
- Holmgren J, "An update on cholera immunity and current and future cholera vaccines", Trop. Med. Infect. Dis, 6, pp.64~ (2021)
- McCarty JM, "Safety and immunogenicity of single-dose live oral cholera vaccine strain CVD 103-HgR in healthy adults age 18-45", Vaccine, 36, pp.833~840 (2018)
- Charles RC, "Plasma and mucosal immunoglobulin M, immunoglobulin A, and immunoglobulin G responses to the Vibrio cholerae O1 protein immunome in adults with cholera in Bangladesh", J. Infect. Dis, 216, pp.125~134 (2017)
- Rashidijahanabad Z, "Virus-like particle display of Vibrio cholerae O-specific polysaccharide as a potential vaccine against cholera", ACS Infect. Dis, 8, pp.574~583 (2022)
- Zareitaher T, "Immunogenic efficacy of DNA and protein-based vaccine from a chimeric gene consisting OmpW, TcpA and CtxB, of Vibrio cholerae", Immunology, 227, pp.152190~ (2022)
- Leitner DR, "A combined vaccine approach against Vibrio cholerae and ETEC based on outer membrane vesicles", Front. Microbiol, 6, pp.823~ (2015)
- Price GA, "Immunization with cholera toxin B subunit induces high-level protection in the suckling mouse model of cholera", PLoS One, 8, pp.e57269~ (2013)
- Jani D, "Expression of cholera toxin B subunit in transgenic tomato plants", Transgenic Res, 11, pp.447~454 (2002)
- Yuki Y, "Oral MucoRice-CTB vaccine for safety and microbiotadependent immunogenicity in humans: a phase 1 randomised trial", Lancet Microbe, 2, pp.e429~e440 (2021)
- Rhie GE, "Construction of a Vibrio cholerae prototype vaccine strain O395-N1-E1 which accumulates cell-associated cholera toxin B subunit", Vaccine, 26, pp.5443~5448 (2008)
- Satchell KJ, "Phenotypic analysis reveals that the 2010 Haiti cholera epidemic is linked to a hypervirulent strain", Infect. Immun, 84, pp.2473~2481 (2016)
- Ghosh P, "Haitian variant Vibrio cholerae O1 strains manifest higher virulence in animal models", Front. Microbiol, 10, pp.111~ (2019)
- Mudrak B, "Specificity of the type II secretion systems of enterotoxigenic Escherichia coli and Vibrio cholerae for heat-labile enterotoxin and cholera toxin", J. Bacteriol, 192, pp.1902~1911 (2010)
- World Health O, "Cholera vaccine: WHO position paper, August 2017 - Recommendations", Vaccine, 36, pp.3418~3420 (2018)
- Harris AM, "Antigen-specific memory B-cell responses to Vibrio cholerae O1 infection in Bangladesh", Infect. Immun, 77, pp.3850~3856 (2009)
- Kauffman RC, "Single-cell analysis of the plasmablast response to Vibrio cholerae demonstrates expansion of cross-reactive memory B cells", mBio, 7, pp.e02021-16~ (2016)
- Ramamurthy T, "Virulence regulation and innate host response in the pathogenicity of Vibrio cholerae", Front. Cell. Infect. Microbiol, 10, pp.572096~ (2020)
- Waldor MK, "Lysogenic conversion by a filamentous phage encoding cholera toxin", Science, 272, pp.1910~1914 (1996)
- Sanchez J, "Expression of cholera toxin under non-AKI conditions in Vibrio cholerae El Tor induced by increasing the exposed surface of cultures", J. Bacteriol, 186, pp.1355~1361 (2004)
- Jonson G, "Expression of virulence factors by classical and El Tor Vibrio cholerae in vivo and in vitro", FEMS Microbiol. Lett, 74, pp.221~228 (1990)
- DiRita VJ, "Differential expression of the ToxR regulon in classical and E1 Tor biotypes of Vibrio cholerae is due to biotype-specific control over toxT expression", Proc. Natl. Acad. Sci. USA, 93, pp.7991~7995 (1996)
- Cobaxin M, "Cholera toxin expression by El Tor Vibrio cholerae in shallow culture growth conditions", Microb. Pathog, 66, pp.5~13 (2014)
- Iwanaga M, "Culture conditions for stimulating cholera toxin production by Vibrio cholerae O1 El Tor", Microbiol. Immunol, 30, pp.1075~1083 (1986)
- Chen WH, "Single-dose live oral cholera vaccine CVD 103-HgR protects against human experimental infection with Vibrio cholerae O1 El Tor", Clin. Infect. Dis, 62, pp.1329~1335 (2016)
- Naha A, "Deciphering the possible role of ctxB7 allele on higher production of cholera toxin by Haitian variant Vibrio cholerae O1", PLoS Negl. Trop. Dis, 14, pp.e0008128~ (2020)
- Kim DW, "The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes", Proc. Natl. Acad. Sci. USA, 102, pp.14046~14051 (2005)
- Donnenberg MS, "Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positiveselection suicide vector", Infect. Immun, 59, pp.4310~4317 (1991)
- Chin CS, "The origin of the Haitian cholera outbreak strain", N. Engl. J. Med, 364, pp.33~42 (2011)
- Mutreja A, "Evidence for several waves of global transmission in the seventh cholera pandemic", Nature, 477, pp.462~465 (2011)